Telix is in a strong financial position with net cash of AUD 140 million as of December 2024. We forecast free cash flow averaging 87% of net income over the next 10 years, and in the absence of major ...
Bausch & Lomb is one of the largest vision care companies in the US. Bausch spun off from its former parent company, Bausch Health, in 2022 and it now operates in three segments: vision care, surgical ...
After Novartis and Roche grew their sales last year, the Swiss pharma giants are handing their CEOs larger compensation packages for 2024. | After Novartis and Roche grew their sales last year, the ...
Updated guidance on preventing atherosclerotic cardiovascular disease in people with dyslipidemia includes changes reflecting ...
UCB’s Bimzelx is firmly on physicians’ radars, with Spherix Global Insights finding that awareness of the drug was tracking ...
Novartis' strong drug pipeline and financials support an 11% annual return by 2027. Learn why NVS stock offers 33% return ...
Since 2021, there’s been an increase in representation of people from underrepresented and underserved communities in Super ...
Breast cancer cases in men only account for 1% of all breast cancer diagnoses. But, knowing the signs, causes, and treatments ...
Do advertisers get the attention they paid for when the big game is a blowout, like Sunday's Super Bowl LIX? Paying $8 ...
This year's Super Bowl commercials went for easy laughs and nostalgia, largely steering clear of controversy and leaving the ...
All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results